1. Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? 
Dimitris Mavridis, PhD 
American Journal of Kidney Diseases 
Volume 67, Issue 5, Pages (May 2016)
DOI: /j.ajkd
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Boxplots show the distribution of publication year in angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) versus placebo/active control. Boxes show the first and third quartiles of the publication year; the horizontal line inside the box shows the second quartile (median). The ends of the whiskers outside the boxes show minimum and maximum publication years.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions